Siklusun 3.Günü Normal FSH Değeri Olan Kadınlarda FSH/LH Oranı ICSI Başarısını Öngörebilir mi?

Abstract

Amaç: Siklusun 3.günü normal FSH değeri olan kadınlarda follikül stimule edici hormon (FSH)/luteinize edici hormon (LH) oranının sitoplazma içi sperm enjeksiyonu (ICSI) başarısının öngörülebilirliğini araştırmak. Hastalar ve Yöntem: Uzun protokol ve rekombinant folikül stimüle edici hormon kullanılarak ICSI tedavisi alan ardışık yüz doksan dokuz infertil kadın retrospektif olarak analiz edildi. Grup A, B, C ve D sırasıyla FSH/LH oranları < 1; ≥ 1 ile < 1.5 arası; ≥ 1.5 ile ≤ 2 arası ve > 2 olan kadınlardan oluşturuldu. Transfer başına klinik gebelik ve implantasyon oranları karşılaştırıldı. Bulgular: Transfer başına klinik gebelik ve implantasyon oranları gruplar arasında benzer idi. Sonuç: Siklusun 3.günü FSH/LH oranı ICSI sikluslarında tedavi sonuçlarını normal 3. gün FSH seviyesi olan kadınlarda öngöremez.

Keywords

• FSH/LH oranı, Gebelik, ICSI, İptal

References

1. 1. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-36. doi: 10.1016/S0015-0282(01)02983-1
2. 2. Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal folliclestimulating hormone level. Fertil Steril 2005;83: 291-301. doi:10.1016/j.fertnstert.2004.10.011
3. 3. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718. doi:10.1093/humupd/dml034
4. 4. Mol BW, Verhagen TE, Hendriks DJ, et al. Value of ovarian reserve testing before IVF: a clinical decision analysis. Hum Reprod 2006;21:1816-23.
5. 5. Muasher SJ, Oehninger S, Simonetti S. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1998;50:298-307.
6. 6. Tanbo T, Dale P O, Lunde O. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citratestimulated follicle-stimulating hormone levels. Fertil Steril 1992;57:819-24.
7. 7. Winslow KL, Toner JP, Brzyski RG. The gonadotrophin releasing hormone agonist stimulation test - a sensitive predictor of performance in the flareup in vitro fertilization cycle. Fertil Steril 1991;56:711-17.
8. 8. Franchin R, De Ziegler D, Olivennes F. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders’ in in vitro fertilization. Hum Reprod 1994; 9:1607-11.

9. 9. Smotrich DB., Widra EA, Gindoff PR. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995; 64: 1136-40.
10. 10. Van er Spuy ZM, Alberts PJ. Ovarian reserve. In: Healy DL, Kovacs GT, McLachlan R, Rodriguez-Armas O, eds. Reproductive Medicine in the Twenty-First Century. London: Parthenon, 2002; 295-305.
11. 11. Sharara FI, Scott RT Jr , Seifer DB. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998; 179: 804-12.
12. 12. Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4.
13. 13. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76. doi: 10.1093/humupd/dmg007
14. 14. Barnhart K, Osherhoff J. Follicule stimulating hormone as a predictor of fertility. Curr Opin Obstet Gynecol 1998;10:227-32.
15. 15. Fasouliotis SJ, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 2000;17:357-73. doi: 10.1023/A:1009465324197
16. 16. Bukman A., Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility Hum Reprod Update 2001;7:581-90. doi: 10.1093/humupd/7.6.581
17. 17. Creus M, Peñarrubia J, Fábregues F, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome Hum Reprod 2000;15:2341-6. doi: 10.1093/humrep/15.11.2341
18. 18. Lass A, Gerrard A, Abusheikha N, Akagbosu F, Brinsden P. IVF performance of women who have fluctuating early follicular FSH levels. J Assist Reprod Genet 2000;17:566-73.
19. 19. Peñarrubia J, Balasch J, Fábregues F, et al. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonistgonadotrophin treatment. Hum Reprod 2000;15:1499-504. doi: 10.1093/humrep/15.7.1499
20. 20. Scott RT Jr, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302.
21. 21. Martin JS, Nisker JA, Tummon IS, Daniel SA, Auckland JL, Feyles V. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril 1996;65:1238-40.
22. 22. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996;65:588-93.
23. 23. Barroso G, Oehninger S, Monzo A, Kolm P, Gibbons WE, Muasher SJ. High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet 2001;18:499-505. doi: 10.1093/humrep/dep254
24. 24. Shrim A, Elizur SE, Seidman DS, Rabinovici J,Wiser A, Dor J. Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response. Reprod Biomed Online 2006;12:418-22.
25. 25. Noci I, Biagiotti R, Maggi M, Ricci F, Cinotti A, Scarselli G. Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod 1998;13:531-4. doi: 10.1093/humrep/ 14.3.863
26. 26. Mukherjee T, Copperman AB, Rosen T. Low day three LH in the presence of a normal baseline FSH predicts a poor response to controlled ovarian hyperstimulation. Abstracts, 51st Annual Meeting of the American Society for Reproductive Medicine, October 7-12, 1995, Seattle, Washington, USA, abstract 0-020:511.
27. 27. Bosch E, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant folliclestimulating hormone and its relationship with cycle outcome. Fertil Steril 2005;84:1529-32. doi:10.1016/j.fertnstert.2005.05.040
28. 28. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update 2006;12:3-12. doi: 10.1093/humupd/dmi030
29. 29. Liu KE, Greenblatt EM. Elevated day 3 follicle-stimulating hormone/ luteinizing hormone ratio ≥ 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles. Fertil Steril 2008;90:297-301.